Cargando…
β-Adrenergic Receptor Inhibitor and Oncolytic Herpesvirus Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects on Colorectal Cancer
Oncolytic viruses (OVs) are considered a promising therapeutic alternative for cancer. However, despite the development of novel OVs with improved efficacy and tumor selectivity, their limited efficacy as monotherapeutic agents remains a significant challenge. This study extended our previously obse...
Autores principales: | Hu, Jiali, Chen, Cuiyu, Lu, Ruitao, Zhang, Yu, Wang, Yang, Hu, Qian, Li, Wanting, Wang, Shiyu, Jing, Ouyang, Yi, Hanying, Zhang, Wei, Chen, Ling, Huang, Weihua, Luo, Jia, McLeod, Howard L., Xu, Ran, He, Yijing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554205/ https://www.ncbi.nlm.nih.gov/pubmed/34721024 http://dx.doi.org/10.3389/fphar.2021.735278 |
Ejemplares similares
-
β-adrenergic receptor inhibition enhances oncolytic herpes virus propagation through STAT3 activation in gastric cancer
por: Hu, Jiali, et al.
Publicado: (2021) -
Propranolol suppresses bladder cancer by manipulating intracellular pH via NHE1
por: Hu, Qian, et al.
Publicado: (2022) -
Induction of Durable Antitumor Response by a Novel Oncolytic Herpesvirus Expressing Multiple Immunomodulatory Transgenes
por: Chouljenko, Dmitry V., et al.
Publicado: (2020) -
Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models
por: Passer, Brent J., et al.
Publicado: (2012) -
Antiangiogenic and Antitumor Effects of Trypanosoma cruzi Calreticulin
por: López, Nandy C., et al.
Publicado: (2010)